img

Global Heparin Injectable Preparation Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Heparin Injectable Preparation Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Heparin Injectable Preparation report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Heparin Injectable Preparation market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Hospital and Clinic are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Heparin Injectable Preparation industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Heparin Injectable Preparation key manufacturers include Sanofi, Shenzhen Techdow Pharmaceutical, Hangzhou Jiuyuan Gene Engineering, Nanjing King-Friend Biochemical Pharmaceutical, Chengdu Baiyu Pharmaceutical, Aspen Pharma, Yantai Dongcheng Biochemicals, Hebei Changshan Biochemical Pharmaceutical and Tianjin Biochemical Pharmaceutical, etc. Sanofi, Shenzhen Techdow Pharmaceutical, Hangzhou Jiuyuan Gene Engineering are top 3 players and held % sales share in total in 2022.
Heparin Injectable Preparation can be divided into Enoxaparin Preparation, Nadroparin Preparation, Dalteparin Sodium Preparation and Unfractionated Heparin Preparation, etc. Enoxaparin Preparation is the mainstream product in the market, accounting for % sales share globally in 2022.
Heparin Injectable Preparation is widely used in various fields, such as Hospital and Clinic, etc. Hospital provides greatest supports to the Heparin Injectable Preparation industry development. In 2022, global % sales of Heparin Injectable Preparation went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Heparin Injectable Preparation market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Sanofi
Shenzhen Techdow Pharmaceutical
Hangzhou Jiuyuan Gene Engineering
Nanjing King-Friend Biochemical Pharmaceutical
Chengdu Baiyu Pharmaceutical
Aspen Pharma
Yantai Dongcheng Biochemicals
Hebei Changshan Biochemical Pharmaceutical
Tianjin Biochemical Pharmaceutical
Zhaoke Pharmaceutical
Vetter Pharma
Changzhou Qianhong Biopharma
Shangdong Huinou Pharmaceutical
Chengdu Hepatunn Pharmaceutical
North China Pharmaceutical
Wanbang Biopharma
Segment by Type
Enoxaparin Preparation
Nadroparin Preparation
Dalteparin Sodium Preparation
Unfractionated Heparin Preparation

Segment by Application


Hospital
Clinic

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Heparin Injectable Preparation market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Heparin Injectable Preparation, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Heparin Injectable Preparation industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Heparin Injectable Preparation in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Heparin Injectable Preparation introduction, etc. Heparin Injectable Preparation Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Heparin Injectable Preparation market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Heparin Injectable Preparation Market Overview
1.1 Heparin Injectable Preparation Product Overview
1.2 Heparin Injectable Preparation Market Segment by Type
1.2.1 Enoxaparin Preparation
1.2.2 Nadroparin Preparation
1.2.3 Dalteparin Sodium Preparation
1.2.4 Unfractionated Heparin Preparation
1.3 Global Heparin Injectable Preparation Market Size by Type
1.3.1 Global Heparin Injectable Preparation Market Size Overview by Type (2018-2029)
1.3.2 Global Heparin Injectable Preparation Historic Market Size Review by Type (2018-2024)
1.3.3 Global Heparin Injectable Preparation Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Heparin Injectable Preparation Sales Breakdown by Type (2018-2024)
1.4.2 Europe Heparin Injectable Preparation Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Heparin Injectable Preparation Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Heparin Injectable Preparation Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Heparin Injectable Preparation Sales Breakdown by Type (2018-2024)
2 Global Heparin Injectable Preparation Market Competition by Company
2.1 Global Top Players by Heparin Injectable Preparation Sales (2018-2024)
2.2 Global Top Players by Heparin Injectable Preparation Revenue (2018-2024)
2.3 Global Top Players by Heparin Injectable Preparation Price (2018-2024)
2.4 Global Top Manufacturers Heparin Injectable Preparation Manufacturing Base Distribution, Sales Area, Product Type
2.5 Heparin Injectable Preparation Market Competitive Situation and Trends
2.5.1 Heparin Injectable Preparation Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Heparin Injectable Preparation Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Heparin Injectable Preparation as of 2022)
2.7 Date of Key Manufacturers Enter into Heparin Injectable Preparation Market
2.8 Key Manufacturers Heparin Injectable Preparation Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Heparin Injectable Preparation Status and Outlook by Region
3.1 Global Heparin Injectable Preparation Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Heparin Injectable Preparation Historic Market Size by Region
3.2.1 Global Heparin Injectable Preparation Sales in Volume by Region (2018-2024)
3.2.2 Global Heparin Injectable Preparation Sales in Value by Region (2018-2024)
3.2.3 Global Heparin Injectable Preparation Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Heparin Injectable Preparation Forecasted Market Size by Region
3.3.1 Global Heparin Injectable Preparation Sales in Volume by Region (2024-2029)
3.3.2 Global Heparin Injectable Preparation Sales in Value by Region (2024-2029)
3.3.3 Global Heparin Injectable Preparation Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Heparin Injectable Preparation by Application
4.1 Heparin Injectable Preparation Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.2 Global Heparin Injectable Preparation Market Size by Application
4.2.1 Global Heparin Injectable Preparation Market Size Overview by Application (2018-2029)
4.2.2 Global Heparin Injectable Preparation Historic Market Size Review by Application (2018-2024)
4.2.3 Global Heparin Injectable Preparation Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Heparin Injectable Preparation Sales Breakdown by Application (2018-2024)
4.3.2 Europe Heparin Injectable Preparation Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Heparin Injectable Preparation Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Heparin Injectable Preparation Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Heparin Injectable Preparation Sales Breakdown by Application (2018-2024)
5 North America Heparin Injectable Preparation by Country
5.1 North America Heparin Injectable Preparation Historic Market Size by Country
5.1.1 North America Heparin Injectable Preparation Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Heparin Injectable Preparation Sales in Volume by Country (2018-2024)
5.1.3 North America Heparin Injectable Preparation Sales in Value by Country (2018-2024)
5.2 North America Heparin Injectable Preparation Forecasted Market Size by Country
5.2.1 North America Heparin Injectable Preparation Sales in Volume by Country (2024-2029)
5.2.2 North America Heparin Injectable Preparation Sales in Value by Country (2024-2029)
6 Europe Heparin Injectable Preparation by Country
6.1 Europe Heparin Injectable Preparation Historic Market Size by Country
6.1.1 Europe Heparin Injectable Preparation Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Heparin Injectable Preparation Sales in Volume by Country (2018-2024)
6.1.3 Europe Heparin Injectable Preparation Sales in Value by Country (2018-2024)
6.2 Europe Heparin Injectable Preparation Forecasted Market Size by Country
6.2.1 Europe Heparin Injectable Preparation Sales in Volume by Country (2024-2029)
6.2.2 Europe Heparin Injectable Preparation Sales in Value by Country (2024-2029)
7 Asia-Pacific Heparin Injectable Preparation by Region
7.1 Asia-Pacific Heparin Injectable Preparation Historic Market Size by Region
7.1.1 Asia-Pacific Heparin Injectable Preparation Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Heparin Injectable Preparation Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Heparin Injectable Preparation Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Heparin Injectable Preparation Forecasted Market Size by Region
7.2.1 Asia-Pacific Heparin Injectable Preparation Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Heparin Injectable Preparation Sales in Value by Region (2024-2029)
8 Latin America Heparin Injectable Preparation by Country
8.1 Latin America Heparin Injectable Preparation Historic Market Size by Country
8.1.1 Latin America Heparin Injectable Preparation Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Heparin Injectable Preparation Sales in Volume by Country (2018-2024)
8.1.3 Latin America Heparin Injectable Preparation Sales in Value by Country (2018-2024)
8.2 Latin America Heparin Injectable Preparation Forecasted Market Size by Country
8.2.1 Latin America Heparin Injectable Preparation Sales in Volume by Country (2024-2029)
8.2.2 Latin America Heparin Injectable Preparation Sales in Value by Country (2024-2029)
9 Middle East and Africa Heparin Injectable Preparation by Country
9.1 Middle East and Africa Heparin Injectable Preparation Historic Market Size by Country
9.1.1 Middle East and Africa Heparin Injectable Preparation Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Heparin Injectable Preparation Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Heparin Injectable Preparation Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Heparin Injectable Preparation Forecasted Market Size by Country
9.2.1 Middle East and Africa Heparin Injectable Preparation Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Heparin Injectable Preparation Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Sanofi
10.1.1 Sanofi Company Information
10.1.2 Sanofi Introduction and Business Overview
10.1.3 Sanofi Heparin Injectable Preparation Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Sanofi Heparin Injectable Preparation Products Offered
10.1.5 Sanofi Recent Development
10.2 Shenzhen Techdow Pharmaceutical
10.2.1 Shenzhen Techdow Pharmaceutical Company Information
10.2.2 Shenzhen Techdow Pharmaceutical Introduction and Business Overview
10.2.3 Shenzhen Techdow Pharmaceutical Heparin Injectable Preparation Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Shenzhen Techdow Pharmaceutical Heparin Injectable Preparation Products Offered
10.2.5 Shenzhen Techdow Pharmaceutical Recent Development
10.3 Hangzhou Jiuyuan Gene Engineering
10.3.1 Hangzhou Jiuyuan Gene Engineering Company Information
10.3.2 Hangzhou Jiuyuan Gene Engineering Introduction and Business Overview
10.3.3 Hangzhou Jiuyuan Gene Engineering Heparin Injectable Preparation Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Hangzhou Jiuyuan Gene Engineering Heparin Injectable Preparation Products Offered
10.3.5 Hangzhou Jiuyuan Gene Engineering Recent Development
10.4 Nanjing King-Friend Biochemical Pharmaceutical
10.4.1 Nanjing King-Friend Biochemical Pharmaceutical Company Information
10.4.2 Nanjing King-Friend Biochemical Pharmaceutical Introduction and Business Overview
10.4.3 Nanjing King-Friend Biochemical Pharmaceutical Heparin Injectable Preparation Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Nanjing King-Friend Biochemical Pharmaceutical Heparin Injectable Preparation Products Offered
10.4.5 Nanjing King-Friend Biochemical Pharmaceutical Recent Development
10.5 Chengdu Baiyu Pharmaceutical
10.5.1 Chengdu Baiyu Pharmaceutical Company Information
10.5.2 Chengdu Baiyu Pharmaceutical Introduction and Business Overview
10.5.3 Chengdu Baiyu Pharmaceutical Heparin Injectable Preparation Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Chengdu Baiyu Pharmaceutical Heparin Injectable Preparation Products Offered
10.5.5 Chengdu Baiyu Pharmaceutical Recent Development
10.6 Aspen Pharma
10.6.1 Aspen Pharma Company Information
10.6.2 Aspen Pharma Introduction and Business Overview
10.6.3 Aspen Pharma Heparin Injectable Preparation Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Aspen Pharma Heparin Injectable Preparation Products Offered
10.6.5 Aspen Pharma Recent Development
10.7 Yantai Dongcheng Biochemicals
10.7.1 Yantai Dongcheng Biochemicals Company Information
10.7.2 Yantai Dongcheng Biochemicals Introduction and Business Overview
10.7.3 Yantai Dongcheng Biochemicals Heparin Injectable Preparation Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Yantai Dongcheng Biochemicals Heparin Injectable Preparation Products Offered
10.7.5 Yantai Dongcheng Biochemicals Recent Development
10.8 Hebei Changshan Biochemical Pharmaceutical
10.8.1 Hebei Changshan Biochemical Pharmaceutical Company Information
10.8.2 Hebei Changshan Biochemical Pharmaceutical Introduction and Business Overview
10.8.3 Hebei Changshan Biochemical Pharmaceutical Heparin Injectable Preparation Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Hebei Changshan Biochemical Pharmaceutical Heparin Injectable Preparation Products Offered
10.8.5 Hebei Changshan Biochemical Pharmaceutical Recent Development
10.9 Tianjin Biochemical Pharmaceutical
10.9.1 Tianjin Biochemical Pharmaceutical Company Information
10.9.2 Tianjin Biochemical Pharmaceutical Introduction and Business Overview
10.9.3 Tianjin Biochemical Pharmaceutical Heparin Injectable Preparation Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Tianjin Biochemical Pharmaceutical Heparin Injectable Preparation Products Offered
10.9.5 Tianjin Biochemical Pharmaceutical Recent Development
10.10 Zhaoke Pharmaceutical
10.10.1 Zhaoke Pharmaceutical Company Information
10.10.2 Zhaoke Pharmaceutical Introduction and Business Overview
10.10.3 Zhaoke Pharmaceutical Heparin Injectable Preparation Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Zhaoke Pharmaceutical Heparin Injectable Preparation Products Offered
10.10.5 Zhaoke Pharmaceutical Recent Development
10.11 Vetter Pharma
10.11.1 Vetter Pharma Company Information
10.11.2 Vetter Pharma Introduction and Business Overview
10.11.3 Vetter Pharma Heparin Injectable Preparation Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Vetter Pharma Heparin Injectable Preparation Products Offered
10.11.5 Vetter Pharma Recent Development
10.12 Changzhou Qianhong Biopharma
10.12.1 Changzhou Qianhong Biopharma Company Information
10.12.2 Changzhou Qianhong Biopharma Introduction and Business Overview
10.12.3 Changzhou Qianhong Biopharma Heparin Injectable Preparation Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Changzhou Qianhong Biopharma Heparin Injectable Preparation Products Offered
10.12.5 Changzhou Qianhong Biopharma Recent Development
10.13 Shangdong Huinou Pharmaceutical
10.13.1 Shangdong Huinou Pharmaceutical Company Information
10.13.2 Shangdong Huinou Pharmaceutical Introduction and Business Overview
10.13.3 Shangdong Huinou Pharmaceutical Heparin Injectable Preparation Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Shangdong Huinou Pharmaceutical Heparin Injectable Preparation Products Offered
10.13.5 Shangdong Huinou Pharmaceutical Recent Development
10.14 Chengdu Hepatunn Pharmaceutical
10.14.1 Chengdu Hepatunn Pharmaceutical Company Information
10.14.2 Chengdu Hepatunn Pharmaceutical Introduction and Business Overview
10.14.3 Chengdu Hepatunn Pharmaceutical Heparin Injectable Preparation Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Chengdu Hepatunn Pharmaceutical Heparin Injectable Preparation Products Offered
10.14.5 Chengdu Hepatunn Pharmaceutical Recent Development
10.15 North China Pharmaceutical
10.15.1 North China Pharmaceutical Company Information
10.15.2 North China Pharmaceutical Introduction and Business Overview
10.15.3 North China Pharmaceutical Heparin Injectable Preparation Sales, Revenue and Gross Margin (2018-2024)
10.15.4 North China Pharmaceutical Heparin Injectable Preparation Products Offered
10.15.5 North China Pharmaceutical Recent Development
10.16 Wanbang Biopharma
10.16.1 Wanbang Biopharma Company Information
10.16.2 Wanbang Biopharma Introduction and Business Overview
10.16.3 Wanbang Biopharma Heparin Injectable Preparation Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Wanbang Biopharma Heparin Injectable Preparation Products Offered
10.16.5 Wanbang Biopharma Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Heparin Injectable Preparation Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Heparin Injectable Preparation Industrial Chain Analysis
11.4 Heparin Injectable Preparation Market Dynamics
11.4.1 Heparin Injectable Preparation Industry Trends
11.4.2 Heparin Injectable Preparation Market Drivers
11.4.3 Heparin Injectable Preparation Market Challenges
11.4.4 Heparin Injectable Preparation Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Heparin Injectable Preparation Distributors
12.3 Heparin Injectable Preparation Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Enoxaparin Preparation
Table 2. Major Company of Nadroparin Preparation
Table 3. Major Company of Dalteparin Sodium Preparation
Table 4. Major Company of Unfractionated Heparin Preparation
Table 5. Global Heparin Injectable Preparation Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Heparin Injectable Preparation Sales by Type (2018-2024) & (K Units)
Table 7. Global Heparin Injectable Preparation Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Heparin Injectable Preparation Sales by Type (2018-2024) & (US& Million)
Table 9. Global Heparin Injectable Preparation Market Share in Value by Type (2018-2024)
Table 10. Global Heparin Injectable Preparation Price by Type (2018-2024) & (US$/Unit)
Table 11. Global Heparin Injectable Preparation Sales by Type (2024-2029) & (K Units)
Table 12. Global Heparin Injectable Preparation Sales Market Share in Volume by Type (2024-2029)
Table 13. Global Heparin Injectable Preparation Sales by Type (2024-2029) & (US$ Million)
Table 14. Global Heparin Injectable Preparation Sales Market Share in Value by Type (2024-2029)
Table 15. Global Heparin Injectable Preparation Price by Type (2024-2029) & (US$/Unit)
Table 16. North America Heparin Injectable Preparation Sales by Type (2018-2024) & (K Units)
Table 17. North America Heparin Injectable Preparation Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Heparin Injectable Preparation Sales (K Units) by Type (2018-2024)
Table 19. Europe Heparin Injectable Preparation Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Heparin Injectable Preparation Sales (K Units) by Type (2018-2024)
Table 21. Asia-Pacific Heparin Injectable Preparation Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Heparin Injectable Preparation Sales (K Units) by Type (2018-2024)
Table 23. Latin America Heparin Injectable Preparation Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Heparin Injectable Preparation Sales (K Units) by Type (2018-2024)
Table 25. Middle East and Africa Heparin Injectable Preparation Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Heparin Injectable Preparation Sales by Company (2018-2024) & (K Units)
Table 27. Global Heparin Injectable Preparation Sales Share by Company (2018-2024)
Table 28. Global Heparin Injectable Preparation Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Heparin Injectable Preparation Revenue Share by Company (2018-2024)
Table 30. Global Market Heparin Injectable Preparation Price by Company (2018-2024) & (US$/Unit)
Table 31. Global Heparin Injectable Preparation Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Heparin Injectable Preparation Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Heparin Injectable Preparation as of 2022)
Table 34. Date of Key Manufacturers Enter into Heparin Injectable Preparation Market
Table 35. Key Manufacturers Heparin Injectable Preparation Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Heparin Injectable Preparation Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Global Heparin Injectable Preparation Sales by Region (2018-2024) & (K Units)
Table 39. Global Heparin Injectable Preparation Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Heparin Injectable Preparation Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Heparin Injectable Preparation Sales Market Share in Value by Region (2018-2024)
Table 42. Global Heparin Injectable Preparation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 43. Global Heparin Injectable Preparation Sales by Region (2024-2029) & (K Units)
Table 44. Global Heparin Injectable Preparation Sales Market Share in Volume by Region (2024-2029)
Table 45. Global Heparin Injectable Preparation Sales by Region (2024-2029) & (US$ Million)
Table 46. Global Heparin Injectable Preparation Sales Market Share in Value by Region (2024-2029)
Table 47. Global Heparin Injectable Preparation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 48. Global Heparin Injectable Preparation Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 49. Global Heparin Injectable Preparation Sales by Application (2018-2024) & (K Units)
Table 50. Global Heparin Injectable Preparation Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Heparin Injectable Preparation Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Heparin Injectable Preparation Sales Market Share in Value by Application (2018-2024)
Table 53. Global Heparin Injectable Preparation Price by Application (2018-2024) & (US$/Unit)
Table 54. Global Heparin Injectable Preparation Sales by Application (2024-2029) & (K Units)
Table 55. Global Heparin Injectable Preparation Sales Market Share in Volume by Application (2024-2029)
Table 56. Global Heparin Injectable Preparation Sales by Application (2024-2029) & (US$ Million)
Table 57. Global Heparin Injectable Preparation Sales Market Share in Value by Application (2024-2029)
Table 58. Global Heparin Injectable Preparation Price by Application (2024-2029) & (US$/Unit)
Table 59. North America Heparin Injectable Preparation Sales by Application (2018-2024) (K Units)
Table 60. North America Heparin Injectable Preparation Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Heparin Injectable Preparation Sales by Application (2018-2024) (K Units)
Table 62. Europe Heparin Injectable Preparation Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Heparin Injectable Preparation Sales by Application (2018-2024) (K Units)
Table 64. Asia-Pacific Heparin Injectable Preparation Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Heparin Injectable Preparation Sales by Application (2018-2024) (K Units)
Table 66. Latin America Heparin Injectable Preparation Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Heparin Injectable Preparation Sales by Application (2018-2024) (K Units)
Table 68. Middle East and Africa Heparin Injectable Preparation Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Heparin Injectable Preparation Sales by Country (2018-2024) & (K Units)
Table 70. North America Heparin Injectable Preparation Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Heparin Injectable Preparation Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Heparin Injectable Preparation Sales Market Share in Value by Country (2018-2024)
Table 73. North America Heparin Injectable Preparation Sales by Country (2024-2029) & (K Units)
Table 74. North America Heparin Injectable Preparation Sales Market Share in Volume by Country (2024-2029)
Table 75. North America Heparin Injectable Preparation Sales by Country (2024-2029) & (US$ Million)
Table 76. North America Heparin Injectable Preparation Sales Market Share in Value by Country (2024-2029)
Table 77. Europe Heparin Injectable Preparation Sales by Country (2018-2024) & (K Units)
Table 78. Europe Heparin Injectable Preparation Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Heparin Injectable Preparation Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Heparin Injectable Preparation Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Heparin Injectable Preparation Sales by Country (2024-2029) & (K Units)
Table 82. Europe Heparin Injectable Preparation Sales Market Share in Volume by Country (2024-2029)
Table 83. Europe Heparin Injectable Preparation Sales by Country (2024-2029) & (US$ Million)
Table 84. Europe Heparin Injectable Preparation Sales Market Share in Value by Country (2024-2029)
Table 85. Asia-Pacific Heparin Injectable Preparation Sales by Region (2018-2024) & (K Units)
Table 86. Asia-Pacific Heparin Injectable Preparation Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Heparin Injectable Preparation Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Heparin Injectable Preparation Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Heparin Injectable Preparation Sales by Region (2024-2029) & (K Units)
Table 90. Asia-Pacific Heparin Injectable Preparation Sales Market Share in Volume by Region (2024-2029)
Table 91. Asia-Pacific Heparin Injectable Preparation Sales by Region (2024-2029) & (US$ Million)
Table 92. Asia-Pacific Heparin Injectable Preparation Sales Market Share in Value by Region (2024-2029)
Table 93. Latin America Heparin Injectable Preparation Sales by Country (2018-2024) & (K Units)
Table 94. Latin America Heparin Injectable Preparation Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Heparin Injectable Preparation Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Heparin Injectable Preparation Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Heparin Injectable Preparation Sales by Country (2024-2029) & (K Units)
Table 98. Latin America Heparin Injectable Preparation Sales Market Share in Volume by Country (2024-2029)
Table 99. Latin America Heparin Injectable Preparation Sales by Country (2024-2029) & (US$ Million)
Table 100. Latin America Heparin Injectable Preparation Sales Market Share in Value by Country (2024-2029)
Table 101. Middle East and Africa Heparin Injectable Preparation Sales by Country (2018-2024) & (K Units)
Table 102. Middle East and Africa Heparin Injectable Preparation Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Heparin Injectable Preparation Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Heparin Injectable Preparation Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Heparin Injectable Preparation Sales by Country (2024-2029) & (K Units)
Table 106. Middle East and Africa Heparin Injectable Preparation Sales Market Share in Volume by Country (2024-2029)
Table 107. Middle East and Africa Heparin Injectable Preparation Sales by Country (2024-2029) & (US$ Million)
Table 108. Middle East and Africa Heparin Injectable Preparation Sales Market Share in Value by Country (2024-2029)
Table 109. Sanofi Company Information
Table 110. Sanofi Introduction and Business Overview
Table 111. Sanofi Heparin Injectable Preparation Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 112. Sanofi Heparin Injectable Preparation Product
Table 113. Sanofi Recent Development
Table 114. Shenzhen Techdow Pharmaceutical Company Information
Table 115. Shenzhen Techdow Pharmaceutical Introduction and Business Overview
Table 116. Shenzhen Techdow Pharmaceutical Heparin Injectable Preparation Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 117. Shenzhen Techdow Pharmaceutical Heparin Injectable Preparation Product
Table 118. Shenzhen Techdow Pharmaceutical Recent Development
Table 119. Hangzhou Jiuyuan Gene Engineering Company Information
Table 120. Hangzhou Jiuyuan Gene Engineering Introduction and Business Overview
Table 121. Hangzhou Jiuyuan Gene Engineering Heparin Injectable Preparation Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 122. Hangzhou Jiuyuan Gene Engineering Heparin Injectable Preparation Product
Table 123. Hangzhou Jiuyuan Gene Engineering Recent Development
Table 124. Nanjing King-Friend Biochemical Pharmaceutical Company Information
Table 125. Nanjing King-Friend Biochemical Pharmaceutical Introduction and Business Overview
Table 126. Nanjing King-Friend Biochemical Pharmaceutical Heparin Injectable Preparation Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 127. Nanjing King-Friend Biochemical Pharmaceutical Heparin Injectable Preparation Product
Table 128. Nanjing King-Friend Biochemical Pharmaceutical Recent Development
Table 129. Chengdu Baiyu Pharmaceutical Company Information
Table 130. Chengdu Baiyu Pharmaceutical Introduction and Business Overview
Table 131. Chengdu Baiyu Pharmaceutical Heparin Injectable Preparation Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 132. Chengdu Baiyu Pharmaceutical Heparin Injectable Preparation Product
Table 133. Chengdu Baiyu Pharmaceutical Recent Development
Table 134. Aspen Pharma Company Information
Table 135. Aspen Pharma Introduction and Business Overview
Table 136. Aspen Pharma Heparin Injectable Preparation Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 137. Aspen Pharma Heparin Injectable Preparation Product
Table 138. Aspen Pharma Recent Development
Table 139. Yantai Dongcheng Biochemicals Company Information
Table 140. Yantai Dongcheng Biochemicals Introduction and Business Overview
Table 141. Yantai Dongcheng Biochemicals Heparin Injectable Preparation Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 142. Yantai Dongcheng Biochemicals Heparin Injectable Preparation Product
Table 143. Yantai Dongcheng Biochemicals Recent Development
Table 144. Hebei Changshan Biochemical Pharmaceutical Company Information
Table 145. Hebei Changshan Biochemical Pharmaceutical Introduction and Business Overview
Table 146. Hebei Changshan Biochemical Pharmaceutical Heparin Injectable Preparation Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 147. Hebei Changshan Biochemical Pharmaceutical Heparin Injectable Preparation Product
Table 148. Hebei Changshan Biochemical Pharmaceutical Recent Development
Table 149. Tianjin Biochemical Pharmaceutical Company Information
Table 150. Tianjin Biochemical Pharmaceutical Introduction and Business Overview
Table 151. Tianjin Biochemical Pharmaceutical Heparin Injectable Preparation Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 152. Tianjin Biochemical Pharmaceutical Heparin Injectable Preparation Product
Table 153. Tianjin Biochemical Pharmaceutical Recent Development
Table 154. Zhaoke Pharmaceutical Company Information
Table 155. Zhaoke Pharmaceutical Introduction and Business Overview
Table 156. Zhaoke Pharmaceutical Heparin Injectable Preparation Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 157. Zhaoke Pharmaceutical Heparin Injectable Preparation Product
Table 158. Zhaoke Pharmaceutical Recent Development
Table 159. Vetter Pharma Company Information
Table 160. Vetter Pharma Introduction and Business Overview
Table 161. Vetter Pharma Heparin Injectable Preparation Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 162. Vetter Pharma Heparin Injectable Preparation Product
Table 163. Vetter Pharma Recent Development
Table 164. Changzhou Qianhong Biopharma Company Information
Table 165. Changzhou Qianhong Biopharma Introduction and Business Overview
Table 166. Changzhou Qianhong Biopharma Heparin Injectable Preparation Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 167. Changzhou Qianhong Biopharma Heparin Injectable Preparation Product
Table 168. Changzhou Qianhong Biopharma Recent Development
Table 169. Shangdong Huinou Pharmaceutical Company Information
Table 170. Shangdong Huinou Pharmaceutical Introduction and Business Overview
Table 171. Shangdong Huinou Pharmaceutical Heparin Injectable Preparation Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 172. Shangdong Huinou Pharmaceutical Heparin Injectable Preparation Product
Table 173. Shangdong Huinou Pharmaceutical Recent Development
Table 174. Chengdu Hepatunn Pharmaceutical Company Information
Table 175. Chengdu Hepatunn Pharmaceutical Introduction and Business Overview
Table 176. Chengdu Hepatunn Pharmaceutical Heparin Injectable Preparation Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 177. Chengdu Hepatunn Pharmaceutical Heparin Injectable Preparation Product
Table 178. Chengdu Hepatunn Pharmaceutical Recent Development
Table 179. North China Pharmaceutical Company Information
Table 180. North China Pharmaceutical Introduction and Business Overview
Table 181. North China Pharmaceutical Heparin Injectable Preparation Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 182. North China Pharmaceutical Heparin Injectable Preparation Product
Table 183. North China Pharmaceutical Recent Development
Table 184. Wanbang Biopharma Company Information
Table 185. Wanbang Biopharma Introduction and Business Overview
Table 186. Wanbang Biopharma Heparin Injectable Preparation Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 187. Wanbang Biopharma Heparin Injectable Preparation Product
Table 188. Wanbang Biopharma Recent Development
Table 189. Key Raw Materials Lists
Table 190. Raw Materials Key Suppliers Lists
Table 191. Heparin Injectable Preparation Market Trends
Table 192. Heparin Injectable Preparation Market Drivers
Table 193. Heparin Injectable Preparation Market Challenges
Table 194. Heparin Injectable Preparation Market Restraints
Table 195. Heparin Injectable Preparation Distributors List
Table 196. Heparin Injectable Preparation Downstream Customers
Table 197. Research Programs/Design for This Report
Table 198. Key Data Information from Secondary Sources
Table 199. Key Data Information from Primary Sources
List of Figures
Figure 1. Heparin Injectable Preparation Product Picture
Figure 2. Global Heparin Injectable Preparation Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Heparin Injectable Preparation Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Heparin Injectable Preparation Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Enoxaparin Preparation
Figure 6. Global Enoxaparin Preparation Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Nadroparin Preparation
Figure 8. Global Nadroparin Preparation Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Product Picture of Dalteparin Sodium Preparation
Figure 10. Global Dalteparin Sodium Preparation Sales YoY Growth (2018-2029) & (K Units)
Figure 11. Product Picture of Unfractionated Heparin Preparation
Figure 12. Global Unfractionated Heparin Preparation Sales YoY Growth (2018-2029) & (K Units)
Figure 13. Global Heparin Injectable Preparation Sales by Type (2018-2029) & (US$ Million)
Figure 14. Global Heparin Injectable Preparation Sales Market Share by Type in 2022 & 2029
Figure 15. North America Heparin Injectable Preparation Sales Market Share in Volume by Type in 2022
Figure 16. North America Heparin Injectable Preparation Sales Market Share in Value by Type in 2022
Figure 17. Europe Heparin Injectable Preparation Sales Market Share in Volume by Type in 2022
Figure 18. Europe Heparin Injectable Preparation Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Heparin Injectable Preparation Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Heparin Injectable Preparation Sales Market Share in Value by Type in 2022
Figure 21. Latin America Heparin Injectable Preparation Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Heparin Injectable Preparation Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Heparin Injectable Preparation Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Heparin Injectable Preparation Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Heparin Injectable Preparation Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Heparin Injectable Preparation Revenue in 2022
Figure 27. Heparin Injectable Preparation Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Hospital
Figure 29. Global Hospital Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Product Picture of Clinic
Figure 31. Global Clinic Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Global Heparin Injectable Preparation Sales by Application (2018-2029) & (US$ Million)
Figure 33. Global Heparin Injectable Preparation Sales Market Share by Application in 2022 & 2029
Figure 34. North America Heparin Injectable Preparation Sales Market Share in Volume by Application in 2022
Figure 35. North America Heparin Injectable Preparation Sales Market Share in Value by Application in 2022
Figure 36. Europe Heparin Injectable Preparation Sales Market Share in Volume by Application in 2022
Figure 37. Europe Heparin Injectable Preparation Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Heparin Injectable Preparation Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Heparin Injectable Preparation Sales Market Share in Value by Application in 2022
Figure 40. Latin America Heparin Injectable Preparation Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Heparin Injectable Preparation Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Heparin Injectable Preparation Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Heparin Injectable Preparation Manufacturing Cost Structure
Figure 45. Heparin Injectable Preparation Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed